Treatment of Intermittent Spotting and Menorrhagia

Initial Diagnostic Evaluation

The American Academy of Family Physicians recommends ruling out pregnancy with beta-hCG testing in a 35-year-old with intermittent spotting and menorrhagia 1
The American Academy of Family Physicians suggests screening for sexually transmitted infections that can cause irregular bleeding in women with intermittent spotting and menorrhagia 1
Evaluation for structural abnormalities, including endometrial polyps, submucosal fibroids, adenomyosis, or malignancy, using transvaginal ultrasonography or saline infusion sonohysterography is recommended by the American Academy of Family Physicians 1
Checking thyroid function (TSH) and prolactin levels is recommended, as thyroid dysfunction and hyperprolactinemia commonly cause ovulatory dysfunction, according to the American Academy of Family Physicians 1

Mefenamic acid 500 mg three times daily for 5-7 days during bleeding episodes reduces menstrual blood loss by 20-60%, as reported by the American College of Obstetricians and Gynecologists 2
The American College of Obstetricians and Gynecologists recommends alternative NSAIDs, including naproxen 440-550 mg every 12 hours or ibuprofen 600-800 mg every 6-8 hours, taken with food 3
Combined hormonal contraceptives, such as oral contraceptive pills, vaginal ring, or transdermal patch, can regulate menstrual cycles and reduce bleeding, according to the American Academy of Family Physicians 1

The Centers for Disease Control and Prevention recommends expecting irregular spotting during the first 3-6 months of use of the levonorgestrel-releasing intrauterine system (LNG-IUS) 4
The American College of Obstetricians and Gynecologists suggests that the LNG-IUS is the most effective medical treatment for menorrhagia, with efficacy comparable to endometrial ablation 4

The American Academy of Family Physicians advises against assuming functional bleeding without excluding structural pathology, especially in a 35-year-old where polyps and fibroids become more common 1
The Centers for Disease Control and Prevention recommends enhanced counseling about expected bleeding patterns to significantly reduce treatment discontinuation rates 5
The American College of Obstetricians and Gynecologists advises against using aspirin for bleeding treatment as it may worsen bleeding 6

In women with irregular menses and breakthrough spotting or light bleeding (after exclusion of pregnancy, infection, endocrine, and structural causes), the CDC recommends a short course of NSAIDs (e.g., mefenamic acid 500 mg TID, naproxen 440–550 mg q12 h, or ibuprofen 600–800 mg q6–8 h for 5–7 days) to reduce menstrual blood loss by approximately 20–60%【7】.

If NSAID therapy does not adequately control spotting or light bleeding, the CDC advises adding a low‑dose combined oral contraceptive (containing 30–35 µg ethinyl estradiol) for 10–20 days during bleeding episodes to achieve better hemostasis【7】.